Thanks to the targeted combination of enormous amounts of data - and with the help of state-of-the-art technologies - patterns can be recognized, diagnoses improved and solutions identified. This applies in particular to the development of new therapeutic approaches and medicines. Hardly any other sector benefits more from this scalability than the healthcare market.
Dr. Severin Schwan, former CEO and current Chairman of the Board of Directors of Roche Holding AG, explains why data is the fuel and linchpin of contemporary research.